Indications and uses
According to homeopathic indications these ingredients provide temporary relief from symptoms of Tinnitus such as: - Ringing - Buzzing - Noises in ears - Pain and Discomfort
Ring Relief
- Manufacturer
- TRP Company
- Effective date
- 2012-05-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:47
Label at a glance#
ProductRing Relief
Active ingredientPotassium Sulfate, Salicylic Acid, Silicon Dioxide, Calcium Sulfate Anhydrous, Quinine Sulfate, Allylthiourea, Citrus Bioflavonoids, Ginkgo, Thiamine, Riboflavin, Niacinamide, Pantothenic Acid, Pyridoxine, Cyanocobalamin, Biotin, Folic Acid, Inositol, Zinc Picolinate, Ascorbic Acid
Label structure12 sections
Dosage and administration
Take 1 caplet, morning and evening, 5 minutes before or 20 minutes after a meal. Let the homeopathic external shell dissolve in your mouth until the sweetness is gone (approx. 20-40 seconds), then swallow the remaining vitamin enriched core with water. For faster results take 1 caplet 3 times per day. For best results, use for at least 6 months. After desired results are achieved, reduce dosing to 1 caplet 2 times...
Contacts and useful links#
Websitewww.trpcompany.com
www.trpcompany.com
www.trpcompany.comLabel contents#
Full prescribing information#
Homeopathic Purpose
| Kali Sulphuricum | 6x | Chirping, Crackling, Humming |
| Salicylicum Acidum | 6x,12x | Roaring, Ringing, Buzzing |
| Silicea | 6x | Pain, Discomfort |
| Calcarea Sulphuricum | 6x | Inner Ear Problems |
| Chininum Sulphuricum | 12x | Hardness of Hearing |
| Thiosinaminum | 6x,12x | Eardrum Problems |
Active Ingredients
| Kali Sulphuricum | 6x |
| Salicylicum Acidum | 6x,12x |
| Silicea | 6x |
| Calcarea Sulphuricum | 6x |
| Chininum Sulphuricum | 12x |
| Thiosinaminum | 6x,12x |
| Citrus Bioflavonoids | 300 mg |
| Ginkgo | 30 mg |
| Thiamine | 0.5 mg |
| Riboflavin | 0.5 mg |
| Niacinamide | 10 mg |
| Pantothenic Acid | 2.5 mg |
| Pyridoxine | 0.5 mg |
| Cyanocobalamin | 200 mcg |
| Biotin | 100 mcg |
| Folic Acid | 200 mcg |
| Inositol | 37.5 mg |
| Zinc Picolinate | 7.5 mg |
| Ascorbic Acid | 150 mg |
Inactive Ingredients
| Sucrose |
| Lactose |
| Microcrystalline cellulose |
| Clear coating |
| Stearic Acid |
| Croscarmellose Sodium |
| Silicon Dioxide |
| Magnesium Stearate |
| Sucralose |
Uses
According to homeopathic indications these ingredients provide temporary relief from
symptoms of Tinnitus such as:
- Ringing
- Buzzing
- Noises in ears
- Pain and Discomfort
Warnings
- Consult with your doctor prior to use if you are currently taking blood thinning medications
or if you are a pregnant or nursing.
- Initial worsening of symptoms may occur.
- If symptoms persist or worsen, consult your doctor.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all medicines out of reach of children.
Do not use
If tamper evident seal is broken.
Stop Use and See A Doctor If
You experience ear pain or prolonged worsening of symptoms.
Directions
Take 1 caplet, morning and evening, 5 minutes before or 20 minutes after a meal. Let the
homeopathic external shell dissolve in your mouth until the sweetness is gone
(approx. 20-40 seconds), then swallow the remaining vitamin enriched core with water.
For faster results take 1 caplet 3 times per day. For best results, use for at least
6 months. After desired results are achieved, reduce dosing to 1 caplet 2 times per day.
Other Information
Tinnitus may be a symptom of a more serious health condition and your doctor should be
consulted for proper diagnosis. Over the counter drugs like aspirin or drugs such as
caffeine and tobacco can aggravate tinnitus. For maximum results, and especially if
earwax build up is an issue, use caplets with Ring Relief Ear Drops.
OTC - QUESTIONS SECTION
TRP Company
1575 Delucchi Lane #115
Reno, NV 89502
888-969-6855
www.trpcompany.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17312-003-12 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ba50-f6ea-e053-dbdaa90aa703 | Ring Relief |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Allylthiourea | ACTIVE INGREDIENT | 706IDJ14B7 | 1 | |
| Ascorbic Acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| Biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| Calcium Sulfate Anhydrous | ACTIVE INGREDIENT | E934B3V59H | 1 | |
| Citrus Bioflavonoids | ACTIVE INGREDIENT | BD70459I50 | 1 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| Ginkgo | ACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| Inositol | ACTIVE INGREDIENT | 4L6452S749 | 1 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| Pantothenic Acid | ACTIVE INGREDIENT | 19F5HK2737 | 1 | |
| Potassium Sulfate | ACTIVE INGREDIENT | 1K573LC5TV | 1 | |
| Pyridoxine | ACTIVE INGREDIENT | KV2JZ1BI6Z | 1 | |
| Quinine Sulfate | ACTIVE INGREDIENT | KF7Z0E0Q2B | 1 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| Salicylic Acid | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| Silicon Dioxide | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Thiamine | ACTIVE INGREDIENT | X66NSO3N35 | 1 | |
| Zinc Picolinate | ACTIVE INGREDIENT | ALO92O31SE | 1 | |
| Allylthiourea | ACTIVE MOIETY | 706IDJ14B7 | 1 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| Biotin | ACTIVE MOIETY | 6SO6U10H04 | 1 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| Citrus Bioflavonoids | ACTIVE MOIETY | BD70459I50 | 1 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| Ginkgo | ACTIVE MOIETY | 19FUJ2C58T | 1 | |
| Inositol | ACTIVE MOIETY | 4L6452S749 | 1 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| Pantothenic Acid | ACTIVE MOIETY | 19F5HK2737 | 1 | |
| Potassium Cation | ACTIVE MOIETY | 295O53K152 | 1 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| Quinine | ACTIVE MOIETY | A7V27PHC7A | 1 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| Salicylic Acid | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| Silicon Dioxide | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| Thiamine | ACTIVE MOIETY | X66NSO3N35 | 1 | |
| Zinc Picolinate | ACTIVE MOIETY | ALO92O31SE | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| Croscarmellose Sodium | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| Lactose | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| Sucralose | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Ring Relief
- Potassium Sulfate, Salicylic Acid, Silicon Dioxide, Calcium Sulfate Anhydrous, Quinine Sulfate, Allylthiourea
- Potassium Sulfate
- Potassium Cation
- Salicylic Acid
- Silicon Dioxide
- Calcium Sulfate Anhydrous
- Calcium Cation
- Quinine Sulfate
- Quinine
- Allylthiourea
- Citrus Bioflavonoids
- Ginkgo
- Thiamine
- Riboflavin
- Niacinamide
- Pantothenic Acid
- Pyridoxine
- Cyanocobalamin
- Biotin
- Folic Acid
- Inositol
- Zinc Picolinate
- Ascorbic Acid
- Sucrose
- Lactose
- Cellulose, Microcrystalline
- Stearic Acid
- Croscarmellose Sodium
- Magnesium Stearate
- Sucralose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17312-003 | 17312-003-12 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Potassium Sulfate | 1K573LC5TV | ACTIB |
| Salicylic Acid | O414PZ4LPZ | ACTIB |
| Silicon Dioxide | ETJ7Z6XBU4 | ACTIB |
| Calcium Sulfate Anhydrous | E934B3V59H | ACTIB |
| Quinine Sulfate | KF7Z0E0Q2B | ACTIB |
| Allylthiourea | 706IDJ14B7 | ACTIB |
| Citrus Bioflavonoids | BD70459I50 | ACTIB |
| Ginkgo | 19FUJ2C58T | ACTIB |
| Thiamine | X66NSO3N35 | ACTIB |
| Riboflavin | TLM2976OFR | ACTIB |
| Niacinamide | 25X51I8RD4 | ACTIB |
| Pantothenic Acid | 19F5HK2737 | ACTIB |
| Pyridoxine | KV2JZ1BI6Z | ACTIB |
| Cyanocobalamin | P6YC3EG204 | ACTIB |
| Biotin | 6SO6U10H04 | ACTIB |
| Folic Acid | 935E97BOY8 | ACTIB |
| Inositol | 4L6452S749 | ACTIB |
| Zinc Picolinate | ALO92O31SE | ACTIB |
| Ascorbic Acid | PQ6CK8PD0R | ACTIB |
| Sucrose | C151H8M554 | IACT |
| Lactose | J2B2A4N98G | IACT |
| Cellulose, Microcrystalline | OP1R32D61U | IACT |
| Stearic Acid | 4ELV7Z65AP | IACT |
| Croscarmellose Sodium | M28OL1HH48 | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Magnesium Stearate | 70097M6I30 | IACT |
| Sucralose | 96K6UQ3ZD4 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, FOR SUSPENSION / ORAL | 1875 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, EXTENDED RELEASE / ORAL | 53 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | PELLET / ORAL | 162 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE / ORAL | 257 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, CHEWABLE / ORAL | 216 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / VAGINAL | 8 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, EFFERVESCENT / ORAL | 1080 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 747751c1-49c6-499c-9f28-93806138de11 | 0a38f93c-cf61-48f0-be17-909c7a6485c6 | 2012-05-31 | Warnings | 747751c1-49c6-499c-9f28-93806138de11 0a38f93c-cf61-48f0-be17-909c7a6485c6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.